Fiche société
University of Arizona
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications3liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| AllopregnanoloneThe purpose of this study is to identifying the intramuscular dose equivalent to the 4mg intravenous dose and assess its safety and tolerability as a weekly injection. | Alzheimer | Phase 1 | À vérifier | United States | À vérifier |
| AllopregnanoloneThe purpose of this study is to identifying the intramuscular dose equivalent to the 4mg intravenous dose and assess its safety and tolerability as a weekly injection. | Alzheimer | Phase 1 | À vérifier | United States | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Allopregnanolone | Alzheimer | Phase 1 | NCT03748303 | Allo-IM — Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study | TERMINATED |
Publications
3| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Allopregnanolone | Distinct Modulation of High- and Low-Frequency Activity by Midazolam and Neurosteroids in Neocortical Slices. | International journal of molecular sciences | ||
| Allopregnanolone | Associations of Allopregnanolone and Related Steroid Hormones with Prenatal Psychosocial Distress in the Healthy Start Cohort. | medRxiv : the preprint server for health sciences | ||
| Allopregnanolone | Brexanolone, a First-In-Class Neurosteroid Medication: Mechanism of Action, Clinical, and Translational Science. | Clinical and translational science |